|
Oxygenta Pharmaceutical Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
296.98 Cr.
|
P/BV
|
-15.12
|
Book Value (Rs.)
|
-5.31
|
|
52 Week High/Low (Rs.)
|
109/30
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
30/09/2019
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | -13.87 | -11.37 | -0.49 | 3.14 | -9.93 |
| | | | | | |
| Net CashFlow From Operating Activities | -13.05 | -1.63 | -1.68 | -1.62 | -6.58 |
| Net Cash Used In Investing Activities | -4.09 | -9.64 | -4.94 | -6.72 | -0.50 |
| Net Cash Used From Financing Activities | 17.13 | 11.22 | 6.33 | 8.67 | 3.19 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | -0.01 | -0.05 | -0.29 | 0.33 | -3.89 |
| Cash And Cash Equivalents Begin of Year | 0.11 | 0.16 | 0.45 | 0.12 | 0.02 |
| Cash And Cash Equivalents End Of Year | 0.10 | 0.11 | 0.16 | 0.45 | -3.87 |
